Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo

Abstract Nanaomycin K, derived from Streptomyces rosa subsp. notoensis OS-3966T, has been discovered to have inhibitory bioactivity on epithelial–mesenchymal transition (EMT), an important mechanism of cancer cell invasion and migration. In this study, we examined the anti-EMT and anti-tumor effect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Koichi Kitagawa, Katsumi Shigemura, Aya Ishii, Takuji Nakashima, Hirotaka Matsuo, Yoko Takahashi, Satoshi Omura, Jun Nakanishi, Masato Fujisawa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0426c214962940b0926b0efcf79f0ab5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0426c214962940b0926b0efcf79f0ab5
record_format dspace
spelling oai:doaj.org-article:0426c214962940b0926b0efcf79f0ab52021-12-02T17:14:58ZNanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo10.1038/s41598-021-88741-32045-2322https://doaj.org/article/0426c214962940b0926b0efcf79f0ab52021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88741-3https://doaj.org/toc/2045-2322Abstract Nanaomycin K, derived from Streptomyces rosa subsp. notoensis OS-3966T, has been discovered to have inhibitory bioactivity on epithelial–mesenchymal transition (EMT), an important mechanism of cancer cell invasion and migration. In this study, we examined the anti-EMT and anti-tumor effect of nanaomycin K in bladder cancer, where EMT has important roles in progression. We treated two bladder cancer lines, non-muscle-invasive KK47 and muscle-invasive T24, with nanaomycin K to determine the effects on cell proliferation, apoptosis and expression of EMT markers in vitro. Wound-healing assays were performed to assess cell invasion and migration. We conducted an in vivo xenograft study in which mice were inoculated with bladder cancer cells and treated with intratumoral administration of nanaomycin K to investigate its anti-tumor and EMT inhibition effects. As the results, nanaomycin K (50 µg/mL) significantly inhibited cell proliferation in KK47 (p < 0.01) and T24 (p < 0.01) in the presence of TGF-β, which is an EMT-inducer. Nanaomycin K (50 µg/mL) also significantly inhibited cell migration in KK47 (p < 0.01) and T24 (p < 0.01), and induced apoptosis in both cell lines in the presence of TGF-β (p < 0.01). Nanaomycin K increased the expression of E-cadherin and inhibited the expression of N-cadherin and vimentin in both cell lines. Nanaomycin K also decreased expression of Snail, Slug, phospho-p38 and phospho-SAPK/JNK especially in T24. Intratumoral administration of nanaomycin K significantly inhibited tumor growth in both KK47 and T24 cells at high dose (1.0 mg/body) (p = 0.009 and p = 0.003, respectively) with no obvious adverse events. In addition, nanaomycin K reversed EMT and significantly inhibited the expression of Ki-67 especially in T24. In conclusion, we demonstrated that nanaomycin K had significant anti-EMT and anti-tumor effects in bladder cancer cells, suggesting that nanaomycin K may be a therapeutic candidate for bladder cancer treatment.Koichi KitagawaKatsumi ShigemuraAya IshiiTakuji NakashimaHirotaka MatsuoYoko TakahashiSatoshi OmuraJun NakanishiMasato FujisawaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Koichi Kitagawa
Katsumi Shigemura
Aya Ishii
Takuji Nakashima
Hirotaka Matsuo
Yoko Takahashi
Satoshi Omura
Jun Nakanishi
Masato Fujisawa
Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
description Abstract Nanaomycin K, derived from Streptomyces rosa subsp. notoensis OS-3966T, has been discovered to have inhibitory bioactivity on epithelial–mesenchymal transition (EMT), an important mechanism of cancer cell invasion and migration. In this study, we examined the anti-EMT and anti-tumor effect of nanaomycin K in bladder cancer, where EMT has important roles in progression. We treated two bladder cancer lines, non-muscle-invasive KK47 and muscle-invasive T24, with nanaomycin K to determine the effects on cell proliferation, apoptosis and expression of EMT markers in vitro. Wound-healing assays were performed to assess cell invasion and migration. We conducted an in vivo xenograft study in which mice were inoculated with bladder cancer cells and treated with intratumoral administration of nanaomycin K to investigate its anti-tumor and EMT inhibition effects. As the results, nanaomycin K (50 µg/mL) significantly inhibited cell proliferation in KK47 (p < 0.01) and T24 (p < 0.01) in the presence of TGF-β, which is an EMT-inducer. Nanaomycin K (50 µg/mL) also significantly inhibited cell migration in KK47 (p < 0.01) and T24 (p < 0.01), and induced apoptosis in both cell lines in the presence of TGF-β (p < 0.01). Nanaomycin K increased the expression of E-cadherin and inhibited the expression of N-cadherin and vimentin in both cell lines. Nanaomycin K also decreased expression of Snail, Slug, phospho-p38 and phospho-SAPK/JNK especially in T24. Intratumoral administration of nanaomycin K significantly inhibited tumor growth in both KK47 and T24 cells at high dose (1.0 mg/body) (p = 0.009 and p = 0.003, respectively) with no obvious adverse events. In addition, nanaomycin K reversed EMT and significantly inhibited the expression of Ki-67 especially in T24. In conclusion, we demonstrated that nanaomycin K had significant anti-EMT and anti-tumor effects in bladder cancer cells, suggesting that nanaomycin K may be a therapeutic candidate for bladder cancer treatment.
format article
author Koichi Kitagawa
Katsumi Shigemura
Aya Ishii
Takuji Nakashima
Hirotaka Matsuo
Yoko Takahashi
Satoshi Omura
Jun Nakanishi
Masato Fujisawa
author_facet Koichi Kitagawa
Katsumi Shigemura
Aya Ishii
Takuji Nakashima
Hirotaka Matsuo
Yoko Takahashi
Satoshi Omura
Jun Nakanishi
Masato Fujisawa
author_sort Koichi Kitagawa
title Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
title_short Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
title_full Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
title_fullStr Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
title_full_unstemmed Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
title_sort nanaomycin k inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0426c214962940b0926b0efcf79f0ab5
work_keys_str_mv AT koichikitagawa nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT katsumishigemura nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT ayaishii nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT takujinakashima nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT hirotakamatsuo nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT yokotakahashi nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT satoshiomura nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT junnakanishi nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
AT masatofujisawa nanaomycinkinhibitedepithelialmesenchymaltransitionandtumorgrowthinbladdercancercellsinvitroandinvivo
_version_ 1718381241231736832